Lipidomics Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Lipidomics Market by Sample Type (Blood Sample, Tissue Sample, Others) By lipid source (Human Source, Animal Source, Plant Source), By Application (Drug Discovery, Biomarker Discovery, Personalized Medicine, Diagnosis and Treatment, Others), By End-user (Biopharmaceutical Companies, Agriculture Industries, Food and Beverage Industries, Academic Research Institutes) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties. Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the market growth over the forecast period. The research includes detailed information on developing trends, market drivers, development opportunities, and market restraints that may affect the industry’s market dynamics. It includes a product, application, and competition analysis, as well as an in-depth examination of the market segments. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.


MARKET SUMMARY
-
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– %
  • Largest Market– North America
  • Fastest Growing Market– Europe

Lipidomics Market

  • The report on lipidomics market gives historical, current, and future market sizes of sample type, service type, lipid source, application, end user and geographic regions.
  • Lipidomics Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Zora Biosciences Oy (Finland)
  • OWL Metabolomics (Spain)
  • ProSciento (U.S.)
  • Avanti Lipids Polar, Inc. (U.S.)
  • VCU Massey Cancer Center (U.S.)
  • Lipotype GmbH (Germany)
  • Metabolon, Inc. (U.S.)
  • Waters Corporation (U.S.)
  • Lipotype GmbH (Germany)
Growth

Lipidomics Market

The rise in need for precise illness diagnosis, the rise in demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. However, the lipidomics market’s growth is hampered by strict regulatory constraints, a lack of modern instruments, a lack of technology acceptance, and a scarcity of professional researchers.


North-America Got Significant Share

North America estimated to account for significant revenue share in global services market owing to huge number of bio pharmaceutical companies focused on the R&D activities of lipidomics, rise in funds from the government organizations, and availability of professional researchers and well-established infrastructure. Europe is expected to expand at significant growth rate due to high adoption of novel technologies; researchers and governments concentrated on prevention of genetic disorders, and increase in target disease conditions. Moreover, increase in population and birth rate, rise in prevalence of diabetes and other targeted diseases, increase in R&D activities in China, Japan, and India, rise in demand for personalized medicine in Asia-Pacific region expected to create significant opportunities for the market over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In September 2016, Lipotype GmbH launched its novel Lipotype shot gun skin lipidomics technology.
  • In June 2015, SCIEX a lifescience analytical technologies company and Metabolon a lipidomics company entered into a multi-year collaboration, and they released The Lipidizer Platform, aan integrated solution for accurate next generation lipidomics.

Key

Key Features of the Report

Lipidomics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Zora Biosciences Oy (Finland)
  • OWL Metabolomics (Spain)
  • ProSciento (U.S.)
  • Avanti Lipids Polar, Inc. (U.S.)
  • The Metabolomics Innovation Centre (U.S.)
  • VCU Massey Cancer Center (U.S.)
  • Virginia Commonwealth University (U.S.)
  • Lipotype GmbH (Germany)
  • School of Medicine (Wayne State University) (U.S.)
  • Metabolon, Inc. (U.S.)
  • Waters Corporation (U.S.)
  • Lipotype GmbH (Germany)

Report

Ask An Analyst

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

Ask An Analyst


Report

Report Customisation


Report

List of Tables and Figures

List of Tables:

Table 01: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Type, 2014-2025

Table 02: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 03: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 04: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Region, 2014-2025

Table 05: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 06: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Type, 2014-2025

Table 07: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 08: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 09: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 10: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Type, 2014-2025

Table 11: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 12: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 13: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 14: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Type, 2014-2025

Table 15: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 16: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By End User, 2014-2025

Table 17: Rest of World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 18: Rest of World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Type, 2014-2025

Table 19: Rest of World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By Sample Source, 2014-2025

Table 20: Rest of World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn), By End User,

2014-2025

List of Figures:

Figure 01: : Global Lipidomics Market Revenue (US$ Mn), by Sample Type (2019 and 2025)

Figure 02: Global Lipidomics Market Revenue Share (%), by Sample Type (2018)

Figure 03: Global Lipidomics Market Revenue (US$ Mn), by Sample Source (2019 and 2025)

Figure 04: Global Lipidomics Market Revenue Share (%), by End User (2018)

Figure 05: Global Lipidomics Market Revenue Share (%), by Region (2018)

Figure 06: Global Lipidomics Market – Regional Revenue Hotspots (2018)

Figure 07: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 08: Global Lipidomics Market – Market Opportunity (US$ Mn), 2017, 2018, & 2025

Figure 09: Global Lipidomics Market Share (%), By Sample Type 2019 & 2025

Figure 10: Global Lipidomics Market Y-o-Y Growth (%), by Sample Type, 2018 – 2025

Figure 11: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Blood Sample Type, 2019 – 2025

Figure 12: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Tissue Sample Type, 2014-2025

Figure 13: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Others, 2014-2025

Figure 15: Global Lipidomics Market Y-o-Y Growth (%), by Sample Source, 2019 – 2025

Figure 16: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Animal Sample Source, 2014-2025

Figure 17: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Human Sample Source, 2014-2025

Figure 18: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Plant Sample Source, 2014-2025

Figure 19: Global Lipidomics Market Share (%), By End User 2019 & 2025

Figure 20: Global Lipidomics Market Y-o-Y Growth (%), by End User, 2018 – 2025

Figure 21: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Healthcare Industry, 2014-2025

Figure 22: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Food Processing Industry, 2014-2025

Figure 23: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Cosmetic Industry, 2014-2025

Figure 24: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Academic & Research Institutes, 2014-2025

Figure 25: Global Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Others, 2014-2025

Figure 26: Global Lipidomics Market Share (%), By Region, 2019 & 2025

Figure 27: Global Lipidomics Market Y-o-Y Growth (%), by Region, 2019 – 2025

Figure 28: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 29: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 30: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, 2014-2025

Figure 31: Rest of the World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 32: Global Lipidomics Market – Opportunity Analysis, By Sample Source, 2019 – 2025

Figure 33: Global Lipidomics Market – Opportunity Analysis, By Sample Type, 2019 – 2025

Figure 34: Global Lipidomics Market – Opportunity Analysis, By End User, 2019 – 2025

Figure 35: Global Lipidomics Market – Opportunity Analysis, By Region, 2019 – 2025

Figure 36: North America Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 37: North America Lipidomics Market – Market Opportunity (US$ Mn), 2017, 2018, & 2025

Figure 38: North America Lipidomics Market Share Analysis(%), by Sample Source, 2018

Figure 39: North America Lipidomics Market Share Analysis (%), by Sample Type, 2018

Figure 40: North America Lipidomics Market Share Analysis (%), by End User, 2018

Figure 41: North America Lipidomics Market Share Analysis (%), by Country, 2018

Figure 42: North America Lipidomics Market – Opportunity Analysis, By Sample Source, 2019 – 2025

Figure 43: North America Lipidomics Market – Opportunity Analysis, By Sample Type, 2019 – 2025

Figure 44: North America Lipidomics Market – Opportunity Analysis, By End User 2019 – 2025

Figure 45: North America Lipidomics Market – Opportunity Analysis, By Country, 2019 – 2025

Figure 46: Europe Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 47: Europe Lipidomics Market – Market Opportunity (US$ Mn), 2017, 2018, & 2025

Figure 48: Europe Lipidomics Market Share Analysis(%), by Sample Source, 2018

Figure 49: Europe Lipidomics Market Share Analysis (%), by Sample Type, 2018

Figure 50: Europe Lipidomics Market Share Analysis (%), by End User, 2018

Figure 51: Europe Lipidomics Market Share Analysis (%), by Country, 2018

Figure 52: Europe Lipidomics Market – Opportunity Analysis, By Sample Source, 2019 – 2025

Figure 53: Europe Lipidomics Market – Opportunity Analysis, By Sample Type, 2019 – 2025

Figure 54: Europe Lipidomics Market – Opportunity Analysis, By End User 2019 – 2025

Figure 55: Europe Lipidomics Market – Opportunity Analysis, By Country, 2019 – 2025

Figure 56: Asia Pacific Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 57: Asia Pacific Lipidomics Market – Market Opportunity (US$ Mn), 2017, 2019, & 20259c

Figure 58: Asia Pacific Lipidomics Market Share Analysis(%), by Sample Source, 2018

Figure 59: Asia Pacific Lipidomics Market Share Analysis (%), by Sample Type, 2018

Figure 60: Asia Pacific Lipidomics Market Share Analysis (%), by End User, 2018

Figure 61: Asia Pacific Lipidomics Market Share Analysis (%), by Country, 2018

Figure 62: Asia Pacific Lipidomics Market – Opportunity Analysis, By Sample Source, 2019 – 2025

Figure 63: Asia Pacific Lipidomics Market – Opportunity Analysis, By Sample Type, 2019 – 2025

Figure 64: Asia Pacific Lipidomics Market – Opportunity Analysis, By End User 2019 – 2025

Figure 65: Asia Pacific Lipidomics Market – Opportunity Analysis, By Country, 2019 – 2025

Figure 66: Rest of World Lipidomics Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2014-2025

Figure 67: Rest of World Lipidomics Market – Market Opportunity (US$ Mn), 2014, 2019, & 2025

Figure 68: Rest of World Lipidomics Market Share Analysis(%), by Sample Source, 2018

Figure 69: Rest of World Lipidomics Market Share Analysis (%), by Sample Type, 2018

Figure 70: Rest of World Lipidomics Market Share Analysis (%), by End User, 2018

Figure 71: Rest of World Lipidomics Market Share Analysis (%), by Country, 2018

Figure 72: Rest of World Lipidomics Market – Opportunity Analysis, By Sample Source, 2019 – 2025

Figure 73: Rest of World Lipidomics Market – Opportunity Analysis, By Sample Type, 2019 – 2025

Figure 74: Rest of World Lipidomics Market – Opportunity Analysis, By End User 2019 – 2025

Figure 75: Rest of World Lipidomics Market – Opportunity Analysis, By Country, 2019 – 2025

Description

Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties. Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the market growth over the forecast period. The research includes detailed information on developing trends, market drivers, development opportunities, and market restraints that may affect the industry’s market dynamics. It includes a product, application, and competition analysis, as well as an in-depth examination of the market segments. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX